Local and global effects of sedation in resting-state fMRI: a randomized, placebo-controlled comparison between etifoxine and alprazolam.

Autor: Wein S; Department of Psychiatry and Psychotherapy, University of Regensburg, Universitätsstrasse 84, Regensburg, 93053, Germany., Riebel M; Department of Psychiatry and Psychotherapy, University of Regensburg, Universitätsstrasse 84, Regensburg, 93053, Germany., Seidel P; Department of Psychiatry and Psychotherapy, University of Regensburg, Universitätsstrasse 84, Regensburg, 93053, Germany., Brunner LM; Department of Psychiatry and Psychotherapy, University of Regensburg, Universitätsstrasse 84, Regensburg, 93053, Germany., Wagner V; Department of Psychiatry and Psychotherapy, University of Regensburg, Universitätsstrasse 84, Regensburg, 93053, Germany., Nothdurfter C; Department of Psychiatry and Psychotherapy, University of Regensburg, Universitätsstrasse 84, Regensburg, 93053, Germany., Rupprecht R; Department of Psychiatry and Psychotherapy, University of Regensburg, Universitätsstrasse 84, Regensburg, 93053, Germany., Schwarzbach JV; Department of Psychiatry and Psychotherapy, University of Regensburg, Universitätsstrasse 84, Regensburg, 93053, Germany. Jens.Schwarzbach@ukr.de.

Publikováno v: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2024 Oct; Vol. 49 (11), pp. 1738-1748. Date of Electronic Publication: 2024 May 31.

The translocator protein 18kDa ligand etifoxine in the treatment of depressive disorders-a double-blind, randomized, placebo-controlled proof-of-concept study.

Autor: Brunner LM; Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Germany. lisa-marie.brunner@medbo.de., Riebel M; Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Germany., Wein S; Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Germany., Koller M; Center for Clinical Studies, University Hospital of Regensburg, Regensburg, Germany., Zeman F; Center for Clinical Studies, University Hospital of Regensburg, Regensburg, Germany., Huppertz G; Center for Clinical Studies, University Hospital of Regensburg, Regensburg, Germany., Emmer T; Center for Clinical Studies, University Hospital of Regensburg, Regensburg, Germany., Eberhardt Y; Center for Clinical Studies, University Hospital of Regensburg, Regensburg, Germany., Schwarzbach J; Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Germany., Rupprecht R; Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Germany., Nothdurfter C; Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Germany.

Publikováno v: Trials [Trials] 2024 Apr 22; Vol. 25 (1), pp. 274. Date of Electronic Publication: 2024 Apr 22.

Promotion of Lymphangiogenesis by Targeted Delivery of VEGF-C Improves Diabetic Wound Healing.

Autor: Brunner LM; Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH) Zurich, 8093 Zurich, Switzerland., He Y; Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH) Zurich, 8093 Zurich, Switzerland., Cousin N; Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH) Zurich, 8093 Zurich, Switzerland., Scholl J; Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH) Zurich, 8093 Zurich, Switzerland., Albin LK; Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH) Zurich, 8093 Zurich, Switzerland., Schmucki B; Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH) Zurich, 8093 Zurich, Switzerland., Supersaxo S; Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH) Zurich, 8093 Zurich, Switzerland., Restivo G; Institute for Dermatology, University Hospital of Zurich, 8091 Zurich, Switzerland., Hafner J; Institute for Dermatology, University Hospital of Zurich, 8091 Zurich, Switzerland., Neri D; Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH) Zurich, 8093 Zurich, Switzerland.; Philochem AG, 8112 Otelfingen, Switzerland., Werner S; Department of Biology, Institute of Molecular Health Sciences, Swiss Federal Institute of Technology (ETH) Zurich, 8093 Zurich, Switzerland., Detmar M; Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH) Zurich, 8093 Zurich, Switzerland.

Publikováno v: Cells [Cells] 2023 Feb 01; Vol. 12 (3). Date of Electronic Publication: 2023 Feb 01.

Non-invasive longitudinal imaging of VEGF-induced microvascular alterations in skin wounds.

Autor: Liu YH; Institute for Biomedical Engineering and Institute of Pharmacology and Toxicology, Faculty of Medicine, University of Zurich, Zurich, Switzerland.; Institute for Biomedical Engineering, Department of Information Technology and Electrical Engineering, ETH Zurich, Zurich, Switzerland., Brunner LM; Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland., Rebling J; Institute for Biomedical Engineering and Institute of Pharmacology and Toxicology, Faculty of Medicine, University of Zurich, Zurich, Switzerland.; Institute for Biomedical Engineering, Department of Information Technology and Electrical Engineering, ETH Zurich, Zurich, Switzerland., Ben-Yehuda Greenwald M; Institute of Molecular Health Sciences, Department of Biology, ETH Zurich, Zurich, Switzerland., Werner S; Institute of Molecular Health Sciences, Department of Biology, ETH Zurich, Zurich, Switzerland., Detmar M; Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland., Razansky D; Institute for Biomedical Engineering and Institute of Pharmacology and Toxicology, Faculty of Medicine, University of Zurich, Zurich, Switzerland.; Institute for Biomedical Engineering, Department of Information Technology and Electrical Engineering, ETH Zurich, Zurich, Switzerland.

Publikováno v: Theranostics [Theranostics] 2022 Jan 01; Vol. 12 (2), pp. 558-573. Date of Electronic Publication: 2022 Jan 01 (Print Publication: 2022).